Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2024 | Continuity of care for patients with hematological predispositions to AML

Anupama Rao, MD, Great Ormond Street Hospital, London, UK, shares insights into examples of recognized hematological predispositions to acute myeloid leukemia (AML) – Runt-related transcription factor 1 familial platelet disorder (RUNX1-FPD) and Shwachman-Diamond syndrome. Considering RUNX1-FPD, which is often diagnosed in newborn babies, Dr Rao reflects on the key clinical questions that must be answered and the necessity of continuity of care and disease monitoring from infancy to adulthood due to the risk of transformation to AML. In the case of Shwachman-Diamond syndrome, a rare, multi-system disorder of inherited bone marrow failure, Dr Rao emphasizes the importance of coordinated multi-specialist care. This interview took place at the 64th Annual Scientific Meeting of the British Society for Haematology (BSH) Congress in Liverpool, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Medical Advisory Board: RUNX1 group.